A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A human endothelial cell-based recycling assay for screening of FcRn targeted molecules ; volume:9 ; number:1 ; day:12 ; month:2 ; year:2018 ; pages:1-14 ; date:12.2018
Nature Communications ; 9, Heft 1 (12.2.2018), 1-14, 12.2018
- Schlagwort
-
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie
- Urheber
-
Grevys, Algirdas
- Beteiligte Personen und Organisationen
-
Nilsen, Jeannette
Sand, Kine M. K.
Daba, Muluneh B.
Øynebråten, Inger
Bern, Malin
McAdam, Martin B.
Foss, Stian
Schlothauer, Tilman
Michaelsen, Terje E.
Christianson, Gregory J.
Roopenian, Derry C.
Blumberg, Richard S.
Sandlie, Inger
Andersen, Jan Terje
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-03061-x
- URN
-
urn:nbn:de:1111-201804143564
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Grevys, Algirdas
- Nilsen, Jeannette
- Sand, Kine M. K.
- Daba, Muluneh B.
- Øynebråten, Inger
- Bern, Malin
- McAdam, Martin B.
- Foss, Stian
- Schlothauer, Tilman
- Michaelsen, Terje E.
- Christianson, Gregory J.
- Roopenian, Derry C.
- Blumberg, Richard S.
- Sandlie, Inger
- Andersen, Jan Terje
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of a potency assay for CD34+ cell-based therapy
The cell biology of the FcRn-albumin recycling system
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A cell-based assay for rapid assessment of ACE2 catalytic function
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
Cell-based Assay for Testing Susceptibility of HIV-1 to Protease Inhibitors
Automated cell-based luminescence assay for profiling antiviral compound activity against enteroviruses
A novel human pluripotent stem cell-based assay to predict developmental toxicity
FaRN! FaRN
Cell-Based Reporter Release Assay to Determine the Potency of Proteolytic Bacterial Neurotoxins
Light-driven polymer recycling to monomers and small molecules
Development of a potency assay for CD34+ cell-based therapy
The cell biology of the FcRn-albumin recycling system
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A cell-based assay for rapid assessment of ACE2 catalytic function
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
Cell-based Assay for Testing Susceptibility of HIV-1 to Protease Inhibitors
Automated cell-based luminescence assay for profiling antiviral compound activity against enteroviruses
A novel human pluripotent stem cell-based assay to predict developmental toxicity
FaRN! FaRN
Cell-Based Reporter Release Assay to Determine the Potency of Proteolytic Bacterial Neurotoxins
Light-driven polymer recycling to monomers and small molecules
Development of a potency assay for CD34+ cell-based therapy
The cell biology of the FcRn-albumin recycling system
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
A cell-based assay for rapid assessment of ACE2 catalytic function
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
Cell-based Assay for Testing Susceptibility of HIV-1 to Protease Inhibitors
Automated cell-based luminescence assay for profiling antiviral compound activity against enteroviruses
A novel human pluripotent stem cell-based assay to predict developmental toxicity
FaRN! FaRN
Cell-Based Reporter Release Assay to Determine the Potency of Proteolytic Bacterial Neurotoxins